Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 60135-1-Ig - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#60135-1-Ig, RRID:AB_2260657
- Product name
- Chromogranin A antibody
- Antibody type
- Monoclonal
- Description
- Chromogranin A antibody (Cat. #60135-1-Ig) is a mouse monoclonal antibody that shows reactivity with human, rat, pig, mouse and has been validated for the following applications: IF, IHC,ELISA.
- Reactivity
- Human, Mouse, Rat, Porcine
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 3H11C11
- Vial size
- 20ul, 150ul
Submitted references Genetic activation of α-cell glucokinase in mice causes enhanced glucose-suppression of glucagon secretion during normal and diabetic states.
Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2.
High throughput proteomic and metabolic profiling identified target correction of metabolic abnormalities as a novel therapeutic approach in head and neck paraganglioma.
Protocol for Differentiation of Human iPSCs into Pulmonary Neuroendocrine Cells.
N‑Myc induces the tumor progression of prostate cancer by regulating FSCN1.
Efficient Generation and Transcriptomic Profiling of Human iPSC-Derived Pulmonary Neuroendocrine Cells.
Cancer cell's neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction.
The zinc transporter Zip14 (SLC39a14) affects Beta-cell Function: Proteomics, Gene expression, and Insulin secretion studies in INS-1E cells.
Bahl V, Lee May C, Perez A, Glaser B, Kaestner KH
Molecular metabolism 2021 Jul;49:101193
Molecular metabolism 2021 Jul;49:101193
Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2.
Liu Q, Pang J, Wang LA, Huang Z, Xu J, Yang X, Xie Q, Huang Y, Tang T, Tong D, Liu G, Wang L, Zhang D, Ma Q, Xiao H, Lan W, Qin J, Jiang J
The Journal of pathology 2021 Jan;253(1):106-118
The Journal of pathology 2021 Jan;253(1):106-118
High throughput proteomic and metabolic profiling identified target correction of metabolic abnormalities as a novel therapeutic approach in head and neck paraganglioma.
Wang Z, Chen H, Xue L, He W, Shu W, Wu H, Wang Z
Translational oncology 2021 Aug;14(8):101146
Translational oncology 2021 Aug;14(8):101146
Protocol for Differentiation of Human iPSCs into Pulmonary Neuroendocrine Cells.
Hor P, Ichida JK, Borok Z, Ryan AL
STAR protocols 2020 Sep 18;1(2):100068
STAR protocols 2020 Sep 18;1(2):100068
N‑Myc induces the tumor progression of prostate cancer by regulating FSCN1.
He G, Li M, Fang L, Xu L, Huang X, Zheng L, Yang L, Luo W, Cai Y, Ma W, Liang C, Yin Y
Oncology reports 2020 Nov;44(5):2265-2274
Oncology reports 2020 Nov;44(5):2265-2274
Efficient Generation and Transcriptomic Profiling of Human iPSC-Derived Pulmonary Neuroendocrine Cells.
Hor P, Punj V, Calvert BA, Castaldi A, Miller AJ, Carraro G, Stripp BR, Brody SL, Spence JR, Ichida JK, Ryan Firth AL, Borok Z
iScience 2020 May 22;23(5):101083
iScience 2020 May 22;23(5):101083
Cancer cell's neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction.
Yin L, Hu P, Shi X, Qian W, Zhau HE, Pandol SJ, Lewis MS, Chung LWK, Wang R
Scientific reports 2020 Jan 27;10(1):1216
Scientific reports 2020 Jan 27;10(1):1216
The zinc transporter Zip14 (SLC39a14) affects Beta-cell Function: Proteomics, Gene expression, and Insulin secretion studies in INS-1E cells.
Maxel T, Smidt K, Petersen CC, Honoré B, Christensen AK, Jeppesen PB, Brock B, Rungby J, Palmfeldt J, Larsen A
Scientific reports 2019 Jun 13;9(1):8589
Scientific reports 2019 Jun 13;9(1):8589
No comments: Submit comment
No validations: Submit validation data